GLP-1 agonist drugs essentially mimic the hormone’s action. Quite a few have been developed, including semaglutide, ...

GLP-1 RAs are associated with a 62% reduction in 5-year mortality in colon cancer patients, especially those with high obesity. The study's findings remained significant after adjusting for ...

Novo Nordisk (NVO) remains a strong buy in the weight loss/diabetes market despite challenges. Read here for an investment ...

THERE is a long list of things that might give you a cough at this time of year – and a new discovery has made a surprising ...

Teva Pharmaceutical Industries stock has drawn renewed attention after consensus analyst price targets edged higher, rising ...